Join the ChEMBL Team!

We are looking for talented individuals to help us maintain and develop the ChEMBL and SureChEMBL resources and currently have a number of open positions within the team. If you are looking for an exciting new role and would like to work with us on the beautiful Wellcome Genome Campus, here are details of the positions:

Data Integration Scientist

We are looking for a Scientist with a passion for data integration to manage the incorporation of drug discovery data into the ChEMBL database.

Responsibilities will include:

Responsibility for the handling, processing and integration of data into the ChEMBL database.

Facilitating the deposition of datasets directly into ChEMBL through working with external collaborators.

Applying text- & data-mining techniques for the development of effective large-scale curation strategies.

Developing methods for the application and maintenance of ontologies in ChEMBL.

Working with other teams to facilitate the integration of data between different EBI resources.

Essential requirements include:

A BSc (or equivalent) in a life-science subject (e.g. biological or biomedical sciences).

3+ years of postgraduate experience in scientific application development, database development or text- & data-mining, with a demonstrable track record of achievement.

Proficient in at least one programming/scripting language (Python knowledge is highly desirable).

Good knowledge of relational databases, data modelling, SQL and PL/SQL, and RESTful web-services.

Experience in integrating diverse data sets.

For full details and to apply for the position, please visit the EMBL website:
https://www.embl.de/jobs/searchjobs/index.php?ref=EBI_01173&newlang=1&loc%5B%5D=2

Software Engineer - Dev Ops

We are seeking a talented Software Engineer/Dev Ops Developer to work on SureChEMBL, one of the largest live resources of chemistry extracted from patent data.

Responsibilities will include:

Maintaining and improving the SureChEMBL system;

Building new monitoring tools and dashboards;

Developing new functionalities in collaboration with colleagues and collaborators;

Profiling and scaling the cloud-based IaaS patent processing pipeline;

Optimizing the application stack for maximum speed and scalability;

Essential requirements include:

A minimum of 3 years of professional development experience;

Strong core Java Enterprise Edition development skills and understanding of Java design principles;

Experience of defining and creating Continuous Integration and Development environments using technologies such as Jenkins, Maven, Artifactory;

A solid understanding of the Open Stack platform;

Experience with distributed queue messaging (e.g. Amazon SQS, RabbitMQ)

Experience with relational databases (mySQL, PostgreSQL);

A solid foundation in computer science, with strong competencies in concurrency, shell scripting, and software design;

For full details and to apply for the position, please visit the EMBL website:
https://www.embl.de/jobs/searchjobs/index.php?ref=EBI_01163&newlang=1&loc%5B%5D=2

Software Engineer - Web Developer

We require a passionate Web Developer who can design and develop robust solutions that deliver ChEMBL data to our extensive user community.

Responsibilities will include:

Developing web-based solutions to better deliver ChEMBL resources to users

Maintaining and further developing the infrastructure that supports interfaces on chemogenomics data

Working with other members of the team, collaborators and users to develop and deliver new and innovative ways to analyse and visualise ChEMBL data

Integrating chemogenomics data with that from other relevant resources at the EBI and beyond

Keeping up-to-date with relevant developments in the field of web development

Essential requirements include:

A BSc (or equivalent) in a technical subject (e.g. life science, computing or mathematics)

3+ years postgraduate experience in front-end software development with a demonstrable track record of delivery

Sound programming skills, including experience of Unix and Python

Experience in building and using web services and good knowledge of current web technologies;

Knowledge of search technologies e.g. Solr/Elastic

Knowledge of relational databases, SQL PL/SQL and NoSQL approaches

Evidence of good practice in software engineering to deliver clean, extensible and robust code through rapid development cycles with documentation and version control

For full details and to apply for the position, please visit the EMBL website:
https://www.embl.de/jobs/searchjobs/index.php?ref=EBI_01174&newlang=1&loc%5B%5D=2

Comments

ChEMBL 34 is out!

We are delighted to announce the release of ChEMBL 34, which includes a full update to drug and clinical candidate drug data. This version of the database, prepared on 28/03/2024 contains: 2,431,025 compounds (of which 2,409,270 have mol files) 3,106,257 compound records (non-unique compounds) 20,772,701 activities 1,644,390 assays 15,598 targets 89,892 documents Data can be downloaded from the ChEMBL FTP site: https://ftp.ebi.ac.uk/pub/databases/chembl/ChEMBLdb/releases/chembl_34/ Please see ChEMBL_34 release notes for full details of all changes in this release: https://ftp.ebi.ac.uk/pub/databases/chembl/ChEMBLdb/releases/chembl_34/chembl_34_release_notes.txt New Data Sources European Medicines Agency (src_id = 66): European Medicines Agency's data correspond to EMA drugs prior to 20 January 2023 (excluding vaccines). 71 out of the 882 newly added EMA drugs are only authorised by EMA, rather than from other regulatory bodies e.g.

New SureChEMBL announcement

(Generated with DALL-E 3 ∙ 30 October 2023 at 1:48 pm) We have some very exciting news to report: the new SureChEMBL is now available! Hooray! What is SureChEMBL, you may ask. Good question! In our portfolio of chemical biology services, alongside our established database of bioactivity data for drug-like molecules ChEMBL , our dictionary of annotated small molecule entities ChEBI , and our compound cross-referencing system UniChem , we also deliver a database of annotated patents! Almost 10 years ago , EMBL-EBI acquired the SureChem system of chemically annotated patents and made this freely accessible in the public domain as SureChEMBL. Since then, our team has continued to maintain and deliver SureChEMBL. However, this has become increasingly challenging due to the complexities of the underlying codebase. We were awarded a Wellcome Trust grant in 2021 to completely overhaul SureChEMBL, with a new UI, backend infrastructure, and new f

Accessing SureChEMBL data in bulk

It is the peak of the summer (at least in this hemisphere) and many of our readers/users will be on holiday, perhaps on an island enjoying the sea. Luckily, for the rest of us there is still the 'sea' of SureChEMBL data that awaits to be enjoyed and explored for hidden 'treasures' (let me know if I pushed this analogy too far). See here and here for a reminder of SureChEMBL is and what it does. This wealth of (big) data can be accessed via the SureChEMBL interface , where users can submit quite sophisticated and granular queries by combining: i) Lucene fields against full-text and bibliographic metadata and ii) advanced structure query features against the annotated compound corpus. Examples of such queries will be the topic of a future post. Once the search results are back, users can browse through and export the chemistry from the patent(s) of interest. In addition to this functionality, we've been receiving user requests for local (behind the

Mapping lists of IDs in ChEMBL

In order to facilitate the mapping of identifiers in ChEMBL, we have developed a new type of search in the ChEMBL Interface. Now, it is possible to enter a list of ChEMBL IDs and see a list of the corresponding entities. Here is an example: 1. Open the ChEMBL Interface , on the main search bar, click on 'Advanced Search': 2. Click on the 'Search by IDs' tab: 3. Select the source entity of the IDs and the destination entity that you want to map to: 4. Enter the identifiers, you can either paste them, or select a file to upload. When you paste IDs, by default it tries to detect the separator. You can also select from a list of separators to force a specific one: Alternatively, you can upload a file, the file can be compressed in GZIP and ZIP formats, this makes the transfer of the file to the ChEMBL servers faster. Examples of the files that can be uploaded to the search by IDs can be found here . 5. Click on the search button: 6. You will be redirected to a search resul

New Drug Approvals - Pt. XVII - Telavancin (Vibativ)

The latest new drug approval, on 11th September 2009 was Telavancin - which was approved for the treatment of adults with complicated skin and skin structure infections (cSSSI) caused by susceptible Gram-positive bacteria , including Staphylococcus aureus , both methicillin-resistant (MRSA) and methicillin-susceptible (MSSA) strains. Telavancin is also active against Streptococcus pyogenes , Streptococcus agalactiae , Streptococcus anginosus group (includes S. anginosus, S. intermedius and S. constellatus ) and Enterococcus faecalis (vancomycin susceptible isolates only). Telavancin is a semisynthetic derivative of Vancomycin. Vancomycin itself is a natural product drug, isolated originally from soil samples in Borneo, and is produced by controlled fermentation of Amycolatopsis orientalis - a member of the Actinobacteria . Telavancin has a dual mechanism of action, firstly it inhibits bacterial cell wall synthesis by interfering with the polymerization and cross-linking of peptid

The ChEMBL-og

Search This Blog